Abstract:L-type large amino acid transporter (LAT) 1, the first light chain (lc) of cluster of differentiation 98 (CD98) to be identified, is associated with the heavy chain (hc) of CD98 and expressed on the surface of various tumor cells irrespective of their origin. Because LAT1 is a 12-pass membrane protein and its possible immunogenic extracellular region is very small, specific monoclonal antibodies (mAb) had not been developed. We report the successful preparation and characterization of mAb recognizing the extracellular domain of human LAT1 protein. Two mAb were selected from hybridoma clones established by fusing mouse myeloma cells and spleen cells from rats immunized against RH7777 rat hepatoma cells expressing recombinant green fluorescent protein fused to human LAT1 protein. Designated SOL22 and SOL69, these mAb specifically reacted with the extracellular domain of LAT1 on cells transfected with cDNA of LAT1, but not with cells transfected with cDNA of other CD98 lc, namely, LAT2, y(+)LAT1, y(+)LAT2, and xCT amino acid transporters. These mAb immunoprecipitated 35- and 90-kDa proteins under reducing conditions in extracts prepared from human HeLa tumor cells, indicating the existence of intermolecular disulfide bonds between cysteine residues in the 90-kDa hc and 35-kDa lc (LAT1). SOL22 and SOL69 mAb reacted with a wide variety of living unfixed human tumor cell lines, but were only weakly reactive with HEK293F human embryonic kidney cells and human peripheral blood cells. Comparative immunohistochemical analyses of normal human tissues with anti-CD98 hc and anti-LAT1 revealed LAT1 to be an excellent molecular target for antibody therapy, possibly even superior to CD98 hc.

Novel Immunohistochemical Monoclonal Antibody Against Rat B Cell Receptor Associated Protein 31 (Bap31)

Monoclonal antibodies against human BAP31 for immunocytochemistry.

[Preparation and Characterization of Monoclonal Antibody Against Human Telomeric Repeat Binding Factor 1].

Generation and Characterisation of Rabbit Monoclonal Antibodies Against the Native Cell Surface Antigens of Embryonic Stem Cells.

BAP31 Plays an Essential Role in Mouse B Cell Development via Regulation of BCR Signaling

Development of a rabbit monoclonal antibody group against Smads and immunocytochemical study of human and mouse embryonic stem cells.

A novel monoclonal antibody against mouse B7-H3 developed in rats.

BAP31 is Involved in T Cell Activation Through TCR Signal Pathways

BAP31, a Promising Target for the Immunotherapy of Malignant Melanomas

BAP31, a Newly Defined Cancer/testis Antigen, Regulates Proliferation, Migration, and Invasion to Promote Cervical Cancer Progression

Preparation and characterization of a specific monoclonal antibody against CIAPIN1.

BAP31 is Frequently Overexpressed in Patients with Primary Colorectal Cancer and Correlates with Better Prognosis

Monoclonal antibody against NRP-1 b1b2.

An Intrabody against B-cell Receptor-Associated Protein 31 (BAP31) Suppresses the Glycosylation of the Epithelial Cell-Adhesion Molecule (EpCAM) via Affecting the Formation of the Sec61-Translocon-Associated Protein (TRAP) Complex

Preparation of Growth Associated Proteins-43 (GAP-43) Polyclone Antibody

[Preparation and Identification of Monoclonal Antibody Against Repression and Activation Protein 1].

A Novel Approach for Rapid High-Throughput Selection of Recombinant Functional Rat Monoclonal Antibodies

Murine Monoclonal Antibodies Generated Against Mouse/Rat Hemokinin-1

New Monoclonal Antibody B7 Selectively Recognizes Rat Myocardium Microvascular Endothelial Cells.

[Preparation and Characterization of the Monoclonal Antibodies to PTD-bcr/abl].

Production and characterization of highly tumor-specific rat monoclonal antibodies recognizing the extracellular domain of human L-type amino-acid transporter 1